US Broker Ratings

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A 216% Upside Potential in the Biotech Sector

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a biopharmaceutical company based in Redwood City, California, has captured the attention of investors in the biotechnology sector. With a market capitalization of $1.78 billion,..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a 52% Upside Potential in Healthcare Tech

As investors navigate the expansive healthcare sector, Waystar Holding Corp. (NASDAQ: WAY) emerges as a noteworthy contender, driven by its robust technology solutions for healthcare payments. With a market capitalization..

Halozyme Therapeutics (HALO) Stock Analysis: A Biotech Powerhouse with 33% Upside Potential

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a frontrunner in the biotechnology sector, is garnering significant attention from investors due to a remarkable 33.22% potential upside, as indicated by analyst target prices...

Oscar Health, Inc. (OSCR) Stock Analysis: A Healthcare Player with a 21.93% Upside Potential

Oscar Health, Inc. (NYSE: OSCR), a key player in the U.S. healthcare plans sector, is drawing attention from investors with its innovative approach and a notable potential upside of 21.93%...

Bausch + Lomb Corporation (BLCO) Stock Analysis: Unlocking an 18.59% Upside in Eye Health Innovation

In the ever-evolving landscape of healthcare, Bausch + Lomb Corporation (NYSE: BLCO) stands as a beacon of innovation and expertise within the medical instruments and supplies industry. With a rich..

Cytokinetics, Inc. (CYTK) Stock Analysis: Exploring a 48.57% Potential Upside in the Biotech Arena

Investors with a keen eye on the biotechnology sector should take a closer look at Cytokinetics, Incorporated (NASDAQ: CYTK), a biopharmaceutical company carving a niche in the realm of muscle..

Natera, Inc. (NTRA) Stock Analysis: Potential 33% Upside with Robust Revenue Growth

Natera, Inc. (NASDAQ: NTRA), a healthcare leader in diagnostics and research, presents a compelling opportunity for investors. With a market cap of $27.68 billion, Natera specializes in molecular testing services,..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unveiling a 22.5% Potential Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, Bio-Rad Laboratories, Inc. (BIO) presents an intriguing proposition. With a market capitalization of $7.14 billion, Bio-Rad operates at the intersection of life..

BrightSpring Health Services (BTSG) Stock Analysis: 27.64% Potential Upside with Strong Buy Ratings

BrightSpring Health Services, Inc. (BTSG) is capturing investor attention with its robust growth trajectory and the solid backing of analyst ratings. Operating within the healthcare sector, specifically in the Health..

Bruker Corporation (BRKR) Stock Analysis: Exploring a Potential 45% Upside

Bruker Corporation (NASDAQ: BRKR), a prominent player in the medical devices industry, is attracting attention from investors seeking opportunities in the healthcare sector. Headquartered in Billerica, Massachusetts, Bruker specializes in..

Chemed Corp (CHE) Stock Analysis: Navigating a 17.20% Potential Upside in the Healthcare Sector

Chemed Corp (NYSE: CHE), a key player in the United States healthcare sector, particularly within the medical care facilities industry, presents an intriguing proposition for investors seeking both stability and..

Corcept Therapeutics (CORT) Stock Analysis: Exploring an 88.80% Potential Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, has caught the eye of investors with its substantial potential upside of 88.80%. Headquartered in Redwood City, California,..

Atrium Therapeutics, Inc. (RNA): Investor Outlook on a Potential 90% Upside

Atrium Therapeutics, Inc. (NASDAQ: RNA), a burgeoning name in the biotechnology sector, is capturing investor attention with its promising pipeline focused on RNA therapeutics for cardiomyopathies. While the stock currently..

Guardant Health, Inc. (GH)

⚠️ No article content returned.

..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Navigating a 19.57% Potential Upside in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH), a stalwart in the healthcare sector specializing in diagnostic and therapeutic products, presents an intriguing opportunity for investors seeking to capitalize on its robust growth..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a Potential 33.87% Upside

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, continues to capture investor attention with its robust operational framework and a potential upside of 33.87%. As..

argenx SE (ARGX) Stock Analysis: Potential Upside Sparks Investor Interest

argenx SE (NASDAQ: ARGX), a leader in the biotechnology sector, stands out with a compelling growth narrative and strong investor interest. Specializing in therapies for autoimmune diseases, argenx operates on..

Amgen Inc. (AMGN) Stock Analysis: Evaluating Growth Potential with a 106.10% ROE

Amgen Inc. (NASDAQ: AMGN) stands as a beacon in the healthcare sector, particularly within the drug manufacturing industry. With a robust market capitalization of $187.49 billion, Amgen is a formidable..

Agilent Technologies, Inc. (A) Stock Analysis: A 46.72% Potential Upside Beckons Investors

Agilent Technologies, Inc. (NYSE: A), a heavyweight in the healthcare sector, particularly within the diagnostics and research industry, stands out with a market capitalization of $31.48 billion. Based in Santa..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring an 81% Potential Upside in the Healthcare Sector

Investors with an eye on the healthcare sector may find iRhythm Holdings, Inc. (NASDAQ: IRTC) an intriguing prospect, especially given its substantial potential upside of 81.46%. As a digital healthcare..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds